title: Acute lymphocytic leukemia in adults: an update.
abstract: The prognosis of adults with acute lymphocytic leukemia has improved over the last two decades. With modern intensive chemotherapy regimens similar to those of pediatric acute lymphocytic leukemia, the complete response rate is 75% to 85%, with a long-term, disease-free survival rate of 20% to 35%. We review the clinical, laboratory, and prognostic features of adult acute lymphocytic leukemia and discuss the results of therapy.
authors.affiliation: Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston.
authors.forename: H A
authors.initials: HA
authors.lastname: Preti
authors.forename: H M
authors.initials: HM
authors.lastname: Kantarjian
mesh_terms: D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D011379:Prognosis; D015996:Survival Rate; D013997:Time Factors